Edition:
United States

Tissue Regenix Group PLC (TRX.L)

TRX.L on London Stock Exchange

15.75GBp
9:35am EDT
Change (% chg)

0.25 (+1.61%)
Prev Close
15.50
Open
15.50
Day's High
15.75
Day's Low
15.75
Volume
155,374
Avg. Vol
286,494
52-wk High
22.00
52-wk Low
15.00

TRX.L

Chart for TRX.L

About

Tissue Regenix Group plc is a medical technology company. The Company is engaged in the development of regenerative products to make replacement native tissue using biological (human and animal) tissues. It operates through Cardiac, Wound Care and Orthopaedics divisions. Its decellularisation (dCELL) technology removes... (more)

Overall

Beta: 1.50
Market Cap(Mil.): £117.82
Shares Outstanding(Mil.): 760.12
Dividend: --
Yield (%): --

Financials

  TRX.L Industry Sector
P/E (TTM): -- 47.98 29.94
EPS (TTM): -0.01 -- --
ROI: -50.71 -2.56 13.01
ROE: -49.91 5.14 14.16

BRIEF-Tissue Regenix Group names new group finance director

* Appointment of Paul Devlin as group finance director and company secretary with immediate effect Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Jan 06 2017

More From Around the Web

Earnings vs. Estimates